They focus on the development of novel antibody therapeutics for regenerative medicine using PDRN and PN.
| Contact Details | 4/F, YeongtongInnoplex II 16675, Suwon-siTel: +82 31 733 9165 |
|---|
Find out more companies
Related products
-
-
-
-
VentureAprogen
Their main modalities include SDR-Grafting, Recombinant Protein Fusion, CHIMPS Bispecific Antibodies, SHOCAP Bispecific Antibodies, and Bitargeting Receptor-Antibody Hybrid
-
VentureK-Cell Co., Ltd.